The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer
- 1 April 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 47 (6), 865-869
- https://doi.org/10.1002/ijc.2910470613
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Monoclonal antibodies reactive with human breast or ovarian carcinoma: In vivo applicationsSeminars in Nuclear Medicine, 1989
- To-Labeled Monoclonal Anti-Carcinoembryonic Antigen Antibody (BW 431/26): Clinical Results in the Detection of Colorectal Carcinomas and RecurrencesScandinavian Journal of Gastroenterology, 1988
- Immunohistochemical localization and molecular characteristics of three monoclonal antibody‐defined epitopes detectable on carcinoembryonic antigen (CEA)International Journal of Cancer, 1985
- The localization of human breast carcinomas by radiolabelled monoclonal antibodiesBritish Journal of Surgery, 1984
- TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURSThe Lancet, 1982
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975